February 16, 2018
Rose
Insulin dose tool gains CE Mark. DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan.
from MobiHealthNews http://ift.tt/2C1C5eT
February 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Science 37, VisualDx, and more digital health deals- Aspire, Penn Medicine team up on $300M fund with built-in accelerators
- Steth IO launches digital stethoscope housed within smartphone case
- First Derm's new AI app helps users identify skin conditions
- Luma Health releases automated two-messaging system for patient engagement
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment